Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO5093151 and RO5027838 in Type 2 Diabetes
NCT00823680Phase 2Completed
- Sponsor
- Roche
- Start
- Apr 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of RO5093151, ro5027838 in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started Apr 2009; status: completed.
02
Drugs
RO5093151ro5027838
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00823680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00823680.